Contribute Try STAT+ Today

“Oh crap,” Kevin Costa thought. A biomechanical engineer, he had labored for months to create miniature hearts, starting with a slurry of stem cells from rats and then coaxing them with chemicals in comfy little lab dishes not only to turn into specialized cardiac cells but also to gallivant around until they formed a three-dimensional, mini-me organ.

As he peered into a jury-rigged beaker held together with binder clips, however, Costa didn’t need a microscope — heck, he didn’t even need reading glasses — to see that something had gone crushingly wrong. The little heart had a hole at one end.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy